Objectives: This study describes exposures to military veterans who participated between 1941 and 1989 in British research at Porton Down on the effects of exposure to chemical warfare agents and to defences against those agents. The study is part of a programme of epidemiological research initiated in response to service veterans' concerns about possible long-term health effects of their participation.
INTRODUCTION
Chemical warfare agents were first used on a mass scale during the First World War, 1914 -1918 . Coleman (2005) has summarized the history of chemical warfare, commenting that, since 1928, first use of chemical weapons has been prohibited in warfare by the Geneva Protocol. Despite this, many countries continued to stockpile chemical weapons and occasionally use them, the most recent example being the Iran-Iraq war (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) . Use and stockpiling of chemical weapons has been prohibited by the 1993 Chemical Weapons Convention (CWC) (Organization for the Prohibition of Chemical Weapons, 1995) . The nerve agent sarin was used by terrorists in Japan in 1995 and Okumura et al. (1998) have described the community emergency response. Riot control agents are banned by the CWC for use in warfare but not for domestic law enforcement and have been widely used in that context (e.g. in Northern Ireland).
After their first use in WW1, the UK government established a facility for research into chemical warfare and defensive measures against it at Porton Down, near Salisbury in southern England. As part of the overall research at Porton Down, servicemen have been enrolled in tests as part of the 'human volunteer programme'. Accounts of the history of the programme can be found in official publications (Carter, 2000; Ministry of Defence, 2006) and in books written by journalists (Harris and Paxman, 1982; Evans, 2000) . At least 30 000 British servicemen are thought to have taken part. One serviceman died at Porton Down in 1953 and, recently, several ex-servicemen have expressed concerns about whether their experience as participants in tests at Porton Down may have damaged their health in the long term. In 2002, the Medical Research Council commissioned a programme of epidemiological research, with funds from the UK Ministry of Defence (MoD) to investigate this. This has included a morbidity survey of members of a veterans support group (Allender et al., 2006) and a cohort study of mortality and cancer morbidity in over 18 000 veterans who attended Porton Down between 1941 and 1989 (Venables et al., 2009 Carpenter et al., 2009 in press) .
A feasibility study was carried out of the quality of records held in the historical archive at Porton Down before the cohort study was finalized. This feasibility study concluded that the records were adequate for an exposure assessment for participants (Keegan et al., 2007) . It was also decided to abstract quantitative data for vesicants and nerve agents because large numbers of veterans had taken part in tests involving these chemicals and, in a high proportion of the tests, quantitative data were available both on exposure and on acute toxic effect. We report here a description of exposures to participants during 1941-1989 based on this exposure assessment.
METHODS

Data abstraction
The MoD made available a collection of archival material of contemporaneous records of those experiments which were part of the 'human volunteer programme' at Porton Down. Details of the provenance of this archive, the assessment of its content and the development of the exposure database have been reported (Keegan et al., 2007) . In brief, data were abstracted from 97 experiment books in the archive and entered into the database as exposures or 'tests'. All tests were recorded, whether or not they involved a chemical warfare agent. Whenever possible, data for each test were linked to a participant. For example, a dermal exposure to an active substance on four separate skin sites, and a placebo on one skin site, in the same participant at the same time was abstracted as five 'tests' to that participant on the same date. Data were abstracted and directly entered onto computers by a team of four trained research staff, all with a science degree, over a 2-year period.
The following data, where available, were abstracted for each test: researcher's initials, date of data abstraction, book number, page number, date of test, the participant's name, military service number and rank. If day of test was missing, the date of the preceding Monday was assigned. During the course of the data abstraction, four additional sources of information were identified by the research team: (i) 'blood books', from which cholinesterase data were abstracted but copies of which were not made available to the team; (ii) records of exposures during chamber tests with nerve agents; (iii) duplicate information about exposures to individual participants in nerve agent tests and (iv) one additional experiment book covering [1984] [1985] [1986] [1987] . The data contained in these documents were crosschecked with data already abstracted from experiment books and any additional data related to human testing within the study period were abstracted.
Early during data abstraction, the researchers noted that benzene (a class 1 carcinogen) had 84 T. J. Keegan et al. sometimes been used as a diluent in chemical tests, but its presence had not been abstracted because it was not the focus of the test. Presence of benzene was abstracted from this point forward (the remaining 99% of records), together with certain other chemicals (e.g. formaldehyde). The researchers also noted instances where a veteran was given medication (e.g. codeine) for an apparently unrelated condition. This was coded as 'treatment only' to allow exclusion from the exposure assessment. Eightythree chemicals and 1863 tests were classified as treatment only. After data abstraction, data relating to whether a test exposure was modified by physical protection were combined (yes to respirator use, non-protective or protective clothing or equipment). For vesicants and nerve agents, data relating to whether a test exposure was modified by chemical protection were combined (yes to antidote, decontaminant or prophylactic).
Data quality
A data abstraction manual was developed before data abstraction began to clarify procedures, and any queries raised by researchers were resolved within the team at least weekly. The large size and complexity of the tests data set precluded double entry of all data. A series of regular data audits were undertaken and involved a random sample of 5% of all data being re-entered. Data from that audit showed that in 11 fields critical to classification of the tests (surname, date of test, exposure type and eight related to the quantification of exposure or acute toxicity), the original and re-entered data were found to be identical or equivalent in 97% of paired comparisons.
Categorization of chemicals
Chemical names were abstracted exactly as recorded in the experimental records. Many chemicals were recorded using more than one name and varied between books and over time. For example, the vesicant 2,29dichlorodiethyl sulphide was recorded as mustard, sulphur mustard, H, HD, HS or HB. Each chemical name was checked using chemical databases (O'Neill, 2001; Chemfinder.com, 2004) and the Porton Down library and with scientists at Porton Down. Synonyms were subsequently grouped together under one 'master' chemical name and, where one existed, the Chemical Abstracts Service registry number was noted. Where close structural synonyms or analogues of a chemical were identified, they too were grouped with a master chemical (e.g. CN and CAP are synonyms of chloroacetophenone; o-nitrochloroacetophenone was classed as an analogue of chloroacetophenone). Chemicals are reported here under the master chemical names, including all associated synonyms and analogues. 
IARC classification
The list of master chemical names was compared with and classified according to the International Agency for Research on Cancer list of chemicals assessed for their carcinogenicity in humans (IARC, 2006) .
Merging of test data to obtain veteran profile
Most visits to Porton Down by participants in the experimental programme between April 1941 and December 1989 lasted 1 or 2 weeks and some visited more than once. It was therefore possible for a participant to have accumulated several tests with the same chemical or with different chemicals. Using the surname and date of test, test data were linked to participants when entered into the database and assigned a predetermined unique study ID number. Test data that initially could not be linked ('unlinked' test data) and other queries were resolved where possible by reference to administrative and experiment records. Some test data could not be reliably linked to a unique person (e.g. anonymized tests and tests involving groups of people). Conversely, there were some participants who were known from administrative records to have attended Porton Down for whom no test data could be assigned. Further details on the assembly and follow-up of the veteran cohort are presented elsewhere (Venables et al., 2009 in press ).
Quantitative measures of exposure and effect
For tests involving vesicants and nerve agents, the following exposure data were also abstracted: exposure site [arm (left/right), leg (left/right), trunk, head, eye, axilla (left/right), scrotum and whole body], duration (days, hours, minutes and seconds), quantity, units of measurement, dilution factor, temperature, humidity and use of decontaminants, antidotes and prophylactics. For vesicants, acute dermal erythema and/or blistering had been documented contemporaneously on semi-quantitative scales. The widest diameter and the diameter perpendicular to that were abstracted in centimetres. Where present, a dimensionless index derived from severity and size of response was also abstracted. For nerve agents, acute effect data abstracted were pupil size (one or both eyes) pre-and post-exposure and up to three measures of cholinesterase activity preand post-exposure: red blood cell cholinesterase, plasma cholinesterase and whole-blood cholinesterase. If several post-exposure activity values were available, the lowest was abstracted. This paper reports data for the most commonly used vesicant (sulphur mustard) and nerve agent (sarin) but quantitative data were abstracted relating to all vesicants and nerve agents.
Sulphur mustard
Dermal exposures to sulphur mustard were documented as number of drops (with diameter), cc, mg, lg, mg m
À3
, g m À2 and mg per 10 g foodstuff. Where practicable, test data were converted to milligrams. Volume measurements were converted to milligrams by assuming that drops were spherical (Ainsworth, 1944) and that the specific gravity of sulphur mustard was 1.27 (Marrs et al., 2007) , with an adjustment for dilution if the records had indicated this. For all mustard sensitivity tests, it was assumed that one 0.01 ml drop of sulphur mustard diluted 1/10 000 with benzene was applied to the skin of the forearm (Porton Down, 1940) . For participants for whom all tests could be expressed in milligrams, cumulative exposure to sulphur mustard was obtained by summing exposure across all tests and all visits. The distribution of cumulative exposure was inspected prior to linkage with the outcome data and cut-points for grouped analyses were derived using participants without any missing data. Some of the participants with incomplete exposure data could be assigned to the 'high'-exposure category, if their incomplete cumulative exposure was higher than the cut-point for the high group.
The erythema and vesicle measurements recorded were condensed into the following categories (original in parentheses): no documented effect (nil), mild erythema (eÀ, eÀÀ, eÀÀÀ, threshold), erythema [e, some effect (severity unrecorded)], marked erythema (eþ, eþþ, eþþþ), vesicle (vesicle, phv, cv, av, vÀ, vÀÀ, vþ, vþþ, vþþþ) and necrosed area (na, nv). Participants with complete dermal effect data were assigned to the maximum effect category recorded in any test. A similar approach to that for exposure was taken in assigning those with incomplete dermal effect data.
Sarin
Most sarin exposures took place in an exposure chamber and chamber exposure was documented contemporaneously as the product of the concentration of sarin in the chamber air and the duration of exposure, expressed in mg min m À3 (Ct). Where Ct was available from both the chamber records and the experiment record, the chamber value was used. If necessary, Ct was calculated from concentration (as mg m
À3
) and duration (as minutes). For participants for whom all tests could be expressed in mg min m À3 , cumulative exposure to sarin was obtained by summing exposure across all tests and all visits. A similar approach to that for sulphur mustard was taken in deriving exposure group cut-points.
The post-exposure cholinesterase activity was expressed as a percentage of the pre-exposure activity. Red cell cholinesterase was taken as the primary measure, where available. If red cell cholinesterase was not available, whole-blood cholinesterase was taken, and if plasma cholinesterase was the only measure, this was used. The smallest post-exposure pupil diameter was expressed as a percentage of the pre-exposure diameter. Where changes in pupil diameter were recorded for both eyes, the maximum percentage fall in diameter has been presented. Participants with complete effect data were assigned to the maximum effect category recorded in any test. A similar approach to that for exposure was taken in assigning those with incomplete effect data.
Exclusions from cohort mortality analysis
The exposures of those included in the cohort mortality analysis (Porton Down veterans) were compared with those excluded: women, civilians, members of non-UK armed forces, those with insufficient identifying information for mortality followup and those excluded on account of missing or discrepant data. Test data which could not be assigned to individual participants because they were anonymous or grouped were also compared, as were those for a random sample of experimental records for 1 January 1939 to 31 March 1941. This period was before military service numbers were routinely recorded in Porton Down archives and identifying information was not sufficient to permit follow-up.
RESULTS
The ''human volunteer programme'' in the study period Data were abstracted for a total of 207 825 tests for the period 1 April 1941 to 31 December 1989 of which 95% (196 994) were linked to 18 176 unique participants. Of these, 873 of these were excluded from the mortality analysis for various reasons (Table 1 ). There were, therefore, 17 303 Porton Down veterans with test data for analysis. The full cohort mortality analysis included 18 276 veterans, i.e. these 17 303 together with a further 973 whose names were in the administrative records but 86 T. J. Keegan et al. to whom no test data could be assigned; they were included in 'no exposure' categories in the cohort mortality analysis. Figure 1( (Fig. 1b) took place predominantly in the 1940s while nerve agent tests (Fig. 1c) were more common in the 1950s and 1960s. Other chemicals (Fig. 1d) were tested throughout the study period and the peak during the 1980s largely reflects tests involving the nerve agent pre-treatment pyridostigmine. 
Chemicals identified in the 'human volunteer programme'
The 147 410 chemical tests assigned to the Porton Down veteran cohort members involved 492 chemicals which were the focus of the test (Table 2) . Table  2 lists each chemical category, the two most tested specific chemicals in each category and all specific chemicals to which at least 1000 Porton Down veterans were exposed. In all, 16 686 of 17 303 veterans had attributable exposure to at least one chemical. The five chemical categories with the largest numbers of Porton Down veterans were vesicants, rubber mixes, treatments, nerve agents and lachrymators. No veterans were tested with blood agents or herbicides. Of the 6984 veterans recorded as involved in non-chemical tests (e.g. psychological or equipment tests), 483 were involved only in non-chemical tests.
Known carcinogens
The results of the linkage with the IARC database (IARC, 2006) are shown in Table 3 . Of the 492 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a Excluded Women Percentages are row percentages of the number of tests in the 'all tests' column; n/a, not available.
Human exposures at Porton Down, 1941 Down, -1989 chemicals, 23 appeared in the IARC database. In all, 10 794 of 16 686 veterans with exposure to at least one chemical were exposed to at least one carcinogen and the largest single group was those exposed to sulphur mustard (10 273). Other large groups were arsenic compounds (1882), nitrogen mustard (1183) and benzene (994). Figure 2 shows that, for most veterans, tests were recorded as having occurred over a short period of time; the median time between the first and last day of testing was 4 days (inter-quartile range 1-8 days). Some veterans visited Porton Down more than once, as indicated by the long gap between first and last tests for some participants (upper bound of range 7732 days) but the actual number of days of testing was few; the median number of days on which participants were involved in tests was two (inter-quartile range 1-4) and, in 90%, all tests took place in up to 16 days (upper bound of range, 47 days).
Timing of exposures
Exposure route and modification of exposure
The exposure route and use of protection (exposure modifiers) differed according to chemical category (Table 4) . Tests involving vesicants were predominantly dermal while most nerve agent tests involved the potential for inhalation exposure and most chemicals classified as treatments were taken orally. Recorded respirator use was unusual, but appeared in almost a third of tests with choking agents. One-third of vesicant and nerve agent tests reported use of a physical barrier (e.g. a nylon film placed on the forearm between the skin and the chemical or piece of uniform material). Specific chemical protection was used in almost 20% of nerve agent tests (e.g. pre-treatment with pyridostigmine) and .40% of vesicant tests (e.g. application of anti-gas ointment).
Quantification of sulphur mustard and nerve agent exposure
Sulphur mustard. Figure 3 shows the cumulative exposure to sulphur mustard for those 6063 (59% of 10 273) veterans in whom all tests with sulphur mustard could be quantified. Some of those veterans (n 5 2183) had a mustard sensitivity test only and were not involved in further tests with sulphur mustard. The quantity of mustard administered in a mustard sensitivity test was small (estimated to be 0.00127 mg) and intended to cause no dermal response in the majority of people. The median was 2.0 mg. After inspection of the distribution, a cut-point at !75th percentile (10.63 mg) was chosen to classify the veterans into 'low' and 'high' cumulative exposure. Any veterans with partial data but cumulative exposure !10.63 mg were assigned to the high group. The numbers in different exposure groups are tabulated in Fig. 3 . (Bars) Number of tests 1940 1950 1960 1970 1980 1990 Year Other chemical tests Human exposures at Porton Down, 1941 Down, -1989 Sulphur mustard exposed veterans were classified by the maximum acute dermal effect to liquid exposure. Those with no missing data were grouped into the following categories: no documented effect (nil) [n 5 2485 (24.2%)], mild erythema [n 5 730 (7.1%)], erythema [n 5 1201 (11.7%)], marked erythema [n 5 1383 (13.5%)] and vesicle or a necrosed area [n 5 3771 (36.4%)] and those with incomplete effect data who could not be categorized. The total for the vesicle and necrosed area group includes veterans with incomplete effect data who were known to have had a vesicle or a necrosed area and were assigned to the relevant group.
Other vesicants. The other vesicants to which .1000 veterans were exposed were Lewisite and the nitrogen mustards. Cumulative exposure to, and dermal effect of, Lewisite and nitrogen mustard was treated similarly to sulphur mustard. The high exposure cut-point for Lewisite was !13.69 mg and 325 (18.6%) veterans were in this group. For nitrogen mustards, the cut-point was !23.73 mg and 337 (28.5%) veterans were in this group. In all, 786 (45%) of those exposed to Lewisite and 361 (30.5%) of those exposed to nitrogen mustards had at least one dermal vesicle or necrosed area.
Sarin. Sarin was the only nerve agent to which .1000 veterans were exposed. The distribution of cumulative exposure to sarin is displayed in Fig. 4 for the 2112 (71% of 2980) for whom all tests with sarin could be assigned an exposure in mg min m
À3
; the median cumulative exposure was 13.8 mg min m À3 . Figure 4 also contains a tabulation of veterans by exposure group according to whether cumulative exposure was high, i.e. !75th percentile (15.0 mg min m À3 ). The maximum unprotected exposure in a sarin inhalation test was 19.6 mg min m À3 and the maximum exposure in any sarin inhalation test was 48.5 mg min m À3 . Figure 5 shows the distribution of maximum percentage change in cholinesterase activity after exposure to sarin. The median was 30% inhibition, 319 veterans (16%) had falls in cholinesterase activity !75% of baseline and 15 greater than 80%. For some veterans (n 5 78, 4%), cholinesterase activity increased after exposure.
There were 365 veterans with complete pupil size data available. For 87 of these, cholinesterase data were also available. The complete distribution is not presented in this paper; the median maximum percentage change after exposure was a reduction in pupil size of 50% (range 0-85%).
Other chemicals. For other chemicals, the number of tests was used as a surrogate for a quantitative measure of exposure. More than 1000 veterans were exposed to 2-chlorobenzal malononitrile (CS), dibenzoxazepine (CR), pralidoxime and atropine and benzene exposure was recorded for close to 1000 veterans (994). Two or more tests were taken as high exposure for CS, CR, pralidoxime, atropine and benzene.
DISCUSSION
The exposure assessment of the Porton Down cohort is important for several reasons. The study was set up to answer questions about the health of a specific group of British military veterans who had participated in a human experimental research programme, but the results may be generalizable to the participants of similar research programmes in other countries, depending on exposure patterns. The results also could be generalizable to occupational groups potentially exposed now or in the past to chemical warfare agents: military personnel, emergency response personnel, laboratory workers and munitions workers. The Tokyo subway sarin incident demonstrated that there is also potential for the general public to be exposed to these agents. Finally, some of the hazardous chemicals considered in this paper have wider uses than chemical warfare and the results from the Porton Down cohort may contribute to understanding of health risks in these groups (for example, nitrogen mustard has been used as a cancer chemotherapeutic agent).
Strengths
The major strengths of this cohort study are the large size of the cohort and the contemporaneous exposure data. The results presented here are based on exposures to 17 303 veterans who attended Porton Down between 1941 and 1989 and who are included Total lower than column sum due to multiple testing within participants.
Human exposures at Porton Down, 1941 Down, -1989 in the cohort mortality analysis (Venables et al., 2009 in press). We believe that this is the largest cohort so far assembled of participants in human research involving chemical warfare agents. Given that exposures in warfare or acts of terrorism are not well documented, the Porton Down cohort may be the largest cohort so far assembled of participants with any documented exposure to chemical warfare agents. Two smaller US experimental cohorts have been studied: one of 1545 US Navy veterans exposed to sulphur mustard (Bullman and Kang, 2000) and another of 6620 servicemen involved in experiments at Edgewood Arsenal with various chemicals including anti-cholinesterase agents (National Research Council, 1982) . The strengths of the contemporaneous exposure data are clear from this paper. Our report on the pilot phase of this study (Keegan et al., 2007) suggested that the Porton Down experimental archive would prove a rich source of data for an exposure assessment. This has proved to be the case, and while the experimental archive varied in style over time, the extent and quality of data appeared to be reasonably consistent over time. Most of the Porton Down archival entries were on individuals, rather than groups, which is rare in epidemiology. The archive also contained considerable quantitative data and a decision was made in the pilot study to abstract quantitative exposure and effect data on vesicants and nerve agents. This paper demonstrates that it will be possible to carry out several methods of exposure-response analysis. As outlined in this paper, analyses of outcome data in pre-defined groups by level of exposure or severity of effect (as a marker of the tissue dose after exposure) will be possible. It will also be clear that exposure-response analyses using continuous variables are feasible. Furthermore, information on exposure modifiers has been collected, such as respirator use. Percentages are row percentages; n/a, not available.
Human exposures at Porton Down, 1941 Down, -1989 Weaknesses In common with most exposure assessments for epidemiology, the main weakness of the exposure assessment is the heterogeneity of some of the exposure groups defined in this paper. There are several types of heterogeneity in the data. Chemicals have been grouped with their close structural analogues. Chemicals with similar acute toxic effects (such as vesicants) have been grouped together. Many veterans were exposed to multiple chemicals. The chemical name abstracted was the chemical which was the main focus of the test and (with certain exceptions) other chemicals such as diluents and skin cleansers were not abstracted. The information on exposure modifiers which has been collected has not yet been applied to the exposure data so, for example, exposures that took place in the exposure chamber are estimated but any personal protective equipment is ignored in the exposure quantification. The pilot study (Keegan et al., 2007) raised the possibility that small amounts of experimental data may be missing from the historical archive in certain years, and so some tests may not have been abstracted. The existence of some unassigned test data means that some of the veterans assigned to no exposure categories in analyses may in fact have been exposed. Heterogeneous exposure groups may lead to misclassification (exposed persons classified as unexposed and vice versa) and dilution (highly exposed persons classified as low exposed and vice versa), so that any real effects on health are obscured. In this research, if there is a genuine mortality or cancer risk in an exposure group where this has occurred, the size of the risk may be underestimated and possibly not detected at all. Sufficient information has been abstracted to address this problem within analyses using approaches that have been taken by other authors. In a cohort of 6620 US servicemen tested at Edgewood Arsenal, non-overlapping groups were assembled in relation to exposure to anti-cholinesterase chemicals (National Research Council, 1982) . In the cohort of 1545 US Navy WW2 veterans exposed to sulphur mustard, analyses by acute dermal effect were carried out (Bullman and Kang, 2000) and this approach is discussed below.
Sulphur mustard and other vesicants
Over 10 000 Porton Down veterans were involved in tests with exposure to sulphur mustard, classified as a lung carcinogen by IARC after epidemiological studies of manufacturing workers in the UK and Japan, and which is also associated with excess mortality from chronic non-malignant lung disease (Wada et al., 1968; Easton et al., 1988) . The careful contemporaneous quantification of exposure for the Porton Down veterans will allow exposure-response analyses and, because their experimental exposures were low, there is a chance to explore the lower end of the exposure-response curve which would be valuable information not only for the Porton Down veterans but for all groups with potential for sulphur mustard exposure. Although it is difficult to compare the experimental exposures with the (unmeasured) exposures in manufacturing workers, .2000 Porton Down veterans had exposures too small to cause any skin reaction, and the median accumulated exposure was only 2.0 mg. The duration of exposure in manufacturing was for work-shifts over months or years but the Porton Down veterans had shorter exposures: the median number of days in which there was exposure to any chemical was 2 days and the median difference in days between a veteran's first and last test of any kind was 4 days. Studies of the effects of exposure to sulphur mustard in WW1 combat veterans are mostly lacking in detailed exposure information (Case and Lea, 1955; Beebe, 1960; Norman, 1975) . However, it is likely that they were intense and lasted for hours. These studies have not shown the same strength of association with respiratory cancers as the studies of occupational exposures, indicating that perhaps repeated exposures over a longer time are important in carcinogenesis.
The Porton Down veterans can also be classified by acute dermal effect which will allow for direct comparisons with the cohort of WW2 US Navy veterans (Bullman and Kang, 2000) . The advantage of an exposure-response analysis using acute dermal Human exposures at Porton Down, 1941 -1989 effect as a marker of tissue dose is that it takes account of any modification by, for example, protective clothing or decontaminants. A review of the health effects of Lewisite and other vesicants commented on the sparse long-term followup health data available for veterans exposed to Lewisite (Pechura and Rall, 1993) . It is therefore notable that this exposure assessment identified 1745 veterans involved in tests with Lewisite exposure (median two tests per veteran) between 1941 and 1954. The fifty-year follow-up period for this group should cover a biologically plausible latent interval for any long-term health effects that might result from this exposure. There were also 1183 veterans exposed to nitrogen mustard.
Sarin and other nerve agents
Sarin was the most frequently tested nerve agent at Porton Down. The exposures generated in the IranIraq war or in the Tokyo subway terrorist incident were unmeasured. In the US cohort of military veterans involved in tests at Edgewood Arsenal, quantitative exposure data were not reported for inhalation exposures (National Research Council, 1982) . In contrast, most exposures at Porton Down were carried out in an exposure chamber and contemporaneous quantitative data are available on exposure. Our data show that the median cumulative exposure was 13.8 mg min m
À3
; the maximum (unprotected) exposure in any one sarin chamber test was 19.6 mg min m À3 and the maximum (protected) exposure was to 48.5 mg min m
. The human inhalation LCt50 of sarin (i.e. the exposure estimated to kill 50% of humans) has been estimated to be 70-100 mg min m À3 (Marrs et al., 2007) . A review of procedures after the death at Porton Down in 1953 recommended that vapour exposures should not exceed 15 mg min m À3 (Ministry of Defence, 2006), a value which was predicted to reduce whole-blood cholinesterase activity by 32-36% with associated symptoms such as chest tightness, runny nose, eye pain and headache (Whitcher, 1959) . In carrying out any future exposure-response analyses for mortality or cancer morbidity, it will be important to take modifiers into account. The exposure route of .80% of nerve agent tests was inhalation, and 20% of tests were modified by respirator use. Twenty per cent of nerve agent exposures were modified with pharmaceutical chemicals, such as pyridostigmine, pralidoxime or atropine.
Data were also available on change in cholinesterase activity and/or pupil size which could be used as a marker of exposure in exposure-response analyses in the future and which takes account of the use of physical or chemical modifiers. Cholinesterase is of two types, butryl-and acetyl-, and these measures mix the two. Interperson and intraperson variability are known to be large. With these caveats, percentage change in cholinesterase activity is available on 70% of the sarin-exposed group. As contextualization, the Health and Safety Executive recommends that a worker exposed to an organophosphate pesticide should be medically reviewed if cholinesterase activity should fall by 30% (Health and Safety Executive, 2000) . Some sarin exposures were high enough to cause a substantial fall in cholinesterase (Fig. 5) .
Other chemicals
A total of 492 different chemicals and their analogues were used in tests in the period covered by the study but only eight were tested on .1000 veterans. The vesicants sulphur mustard, Lewisite and nitrogen mustards and the nerve agent sarin have been discussed above. The remaining four chemicals were the nerve agent treatments pralidoxime and atropine and the riot control agents CS and CR. Initial analyses of mortality will be restricted to these eight chemicals. The carcinogen benzene was tested in almost 1000 veterans (n 5 994) and will be added to the initial analysis of cancer morbidity. Pralidoxime, atropine, CS and CR are of interest not only in relation to the Porton Down veterans but also in relation to other military and emergency services populations. If the analyses show increased risks of any causes of death or types of cancer, then nested case-control analyses could be carried out to examine risk in relation to the full range of chemicals on which data were abstracted.
The Porton Down experimental archive has proved to be a rich source of exposure data for investigation of the long-term health effects of acute low-level exposures to the chemicals associated with chemical weapons research. We have been able to categorize 17 303 veterans into exposure groups. The large size of the cohort and of some of these exposure groups, together with the relatively complete exposure data, will aid interpretation of the results of the epidemiological analysis.
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